Skip to main content
# Title Department Research Member Research Year
1001 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2015
1002 Effect of Immunonutrition on Postoperative Complications in patients Undergoing Gastrointestinal Cancer Surgery
Department of Anesthesia, Intensive care and Pain management Prof. Mustafa Galal Mustafa Hassan 2015
1003 Vergleich der Biologisch Effektiven Dosen bei der Brustbestrahlung mittels Simultan Integriertem und Sequentiellem Boost Department of Radiotherapy and Nuclear medicine Dr. Moamen Mohamed Omran Moustafa Aly 2015
1004 • Outcome of patients with glioblastoma in Saudi Arabia: Single center experience. Department of Medical Oncology Dr. Ashraf Mohamed El-Yamany 2015
1005 Prognostic Value of KRAS Mutations in Codons 12 and 13 in South Egyptian Colorectal Cancer Patients Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2015
1006 Clinicolaboratory Characteristics and Treatment Outcome of Pediatric Acute Lymphoblastic Leukemia at South Egypt Cancer Institute Department of Pediatric Oncology Dr. Aminh Naje Abdul Hameed Jad Elarab 2015
1007 Analgesic efficacy of intravenous morphine, tramadol
and ketorolac on postoperative pain in patients
undergoing modified radical mastectomy
Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2015
1008 A Retrospective Study of Survival and Patterns of Failure in Gastric Cancer after Adjuvant Chemoradiation
...
Department of Radiotherapy and Nuclear medicine Dr. Alia Mohamed Ali Attia 2015
1009 Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. Department of Radiotherapy and Nuclear medicine Prof. Mohamed Ibrahim Mohamed El-Sayed 2015
1010 • Small Cell Lung Cancer ( SCLC) in Never Smokers And Response To Oral Tyrosine Kinase Inhibitors (TKI): Case Report Department of Medical Oncology Dr. Ashraf Mohamed El-Yamany 2015